Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sneha Johnson"'
Publikováno v:
International Journal of Computing and Digital Systems. 12:121-130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6c9b291af47519a0afc54fd902aa89f
https://doi.org/10.12785/ijcds/1201011
https://doi.org/10.12785/ijcds/1201011
Autor:
Melissa Duarte, Mahsa Zarei, Henry W. Long, Amin Nassar, Sneha Johnson, Krinio Giannikou, Heng Du, Heng-Jia Liu, Hans R. Widlund, Elizabeth P. Henske, David J. Kwiatkowski
Publikováno v:
Oncogene
Tuberous sclerosis complex (TSC) is an autosomal dominant tumor suppressor syndrome, characterized by tumor development in multiple organs, including renal angiomyolipoma. Biallelic loss of TSC1 or TSC2 is a known genetic driver of angiomyolipoma dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::631bbf64182ba8e1acd292b77da41629
http://europepmc.org/articles/PMC7796905
http://europepmc.org/articles/PMC7796905
Autor:
Ali Vaziri-Gohar, Rupesh Shrestha, Sneha Johnson, Zuhua Yu, Keshav Karki, Larry J. Suva, Stephen Safe, Heng Du, Jessica Epps, Mehrdad Zarei, Mahsa Zarei
Publikováno v:
Cancer Res Commun
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis and chemotherapy with gemcitabine has limited effects and is associated with development of drug resistance. Treatment of Panc1 and MiaPaca2 pancreatic cancer c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0217e0a55803b24cf7c62d506b682176
https://europepmc.org/articles/PMC9109828/
https://europepmc.org/articles/PMC9109828/
Autor:
Elizabeth P. Henske, John M. Asara, Heng Du, Hilaire C. Lam, Yubao Wang, Rachel E. Yan, Mahsa Zarei, Amin Nassar, David J. Kwiatkowski, Sneha Johnson, Tinghu Zhang, Krinio Giannikou
Publikováno v:
The Journal of Experimental Medicine
Tuberous sclerosis complex (TSC) is a genetic disorder in which tumors develop due to TSC1/TSC2 loss and activation of mTORC1. Zarei et al. show that TSC tumors are sensitive to CDK7 inhibition, which reduces expression of NRF2 and glutathione synthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c1d344b0cbc02acf800e41fba755607
http://europepmc.org/articles/PMC6829598
http://europepmc.org/articles/PMC6829598